Creative Planning’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.03M Buy
283,330
+53,660
+23% +$195K ﹤0.01% 1818
2025
Q1
$441K Buy
229,670
+63,367
+38% +$122K ﹤0.01% 2394
2024
Q4
$316K Buy
166,303
+50,131
+43% +$95.2K ﹤0.01% 2610
2024
Q3
$153K Buy
116,172
+5,482
+5% +$7.24K ﹤0.01% 2927
2024
Q2
$113K Hold
110,690
﹤0.01% 2804
2024
Q1
$203K Hold
110,690
﹤0.01% 2552
2023
Q4
$137K Buy
110,690
+262
+0.2% +$325 ﹤0.01% 2514
2023
Q3
$126K Buy
+110,428
New +$126K ﹤0.01% 2345
2021
Q2
Sell
-14,653
Closed -$50K 1987
2021
Q1
$50K Sell
14,653
-30,999
-68% -$106K ﹤0.01% 2261
2020
Q4
$128K Buy
45,652
+32,000
+234% +$89.7K ﹤0.01% 1941
2020
Q3
$34K Buy
13,652
+782
+6% +$1.95K ﹤0.01% 1883
2020
Q2
$175K Hold
12,870
﹤0.01% 1543
2020
Q1
$98K Hold
12,870
﹤0.01% 1516
2019
Q4
$81K Sell
12,870
-3,692
-22% -$23.2K ﹤0.01% 1759
2019
Q3
$65K Sell
16,562
-474
-3% -$1.86K ﹤0.01% 1748
2019
Q2
$82K Sell
17,036
-307
-2% -$1.48K ﹤0.01% 1748
2019
Q1
$142K Sell
17,343
-2,245
-11% -$18.4K ﹤0.01% 1631
2018
Q4
$108K Buy
19,588
+8,938
+84% +$49.3K ﹤0.01% 1611
2018
Q3
$94K Hold
10,650
﹤0.01% 1781
2018
Q2
$106K Sell
10,650
-15,720
-60% -$156K ﹤0.01% 1743
2018
Q1
$251K Buy
26,370
+15,720
+148% +$150K ﹤0.01% 1448
2017
Q4
$158K Hold
10,650
﹤0.01% 1656
2017
Q3
$209K Hold
10,650
﹤0.01% 1566
2017
Q2
$153K Buy
10,650
+300
+3% +$4.31K ﹤0.01% 1665
2017
Q1
$95K Sell
10,350
-500
-5% -$4.59K ﹤0.01% 1981
2016
Q4
$113K Sell
10,850
-26,500
-71% -$276K ﹤0.01% 1769
2016
Q3
$338K Hold
37,350
﹤0.01% 1112
2016
Q2
$279K Sell
37,350
-12,650
-25% -$94.5K ﹤0.01% 1085
2016
Q1
$451K Buy
50,000
+25,000
+100% +$226K ﹤0.01% 787
2015
Q4
$323K Buy
25,000
+20,000
+400% +$258K ﹤0.01% 949
2015
Q3
$48K Buy
+5,000
New +$48K ﹤0.01% 2053